← Eichor
Condition: Glycogen Storage Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Glycogen Storage Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

GSD VI and GSD IX Natural History
Phase N/A · 1 location(s) · Duke University · NCT04454216Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease
Phase N/A · 2 location(s) · Weill Medical College of Cornell University · NCT05085704Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
Phase 2 · 28 location(s) · Shionogi · NCT07123155Cognitive and Neurological Pathologies in Pompe Disease
Phase N/A · 1 location(s) · Duke University · NCT04639336FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169Rare Glycogen Storage Diseases Natural History Study
Phase N/A · 1 location(s) · Duke University · NCT06795152Pompe Disease Registry Protocol
Phase N/A · 272 location(s) · Genzyme, a Sanofi Company · NCT00231400French Observatory for Patients with Type 3 Glycogenosis
Phase N/A · 3 location(s) · Institut de Myologie, France · NCT06616545China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD
Phase 4 · 1 location(s) · Genzyme, a Sanofi Company · NCT06666413Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
Phase N/A · 1 location(s) · Duke University · NCT01665326GBE Deficiency (GSD IV and APBD) Natural History Study
Phase N/A · 1 location(s) · Duke University · NCT02683512'Glycogen Storage Diseases (GSDs) in Indian Children- Establishing an Indian GSD (I-GSD) Registry'
Phase N/A · 3 location(s) · Institute of Liver and Biliary Sciences, India · NCT06396546Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06833489Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06813443A Long-term Study for the Outcome of Pompe Disease
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT02399748Use of Continuous Glucose Monitoring to Evaluate Postprandial Response to Raw Cornstarch Supplementation in Adult Glycog
Phase N/A · 1 location(s) · Federico II University · NCT07645898Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168A Global Prospective Observational Registry of Patients With Pompe Disease
Phase N/A · 41 location(s) · Amicus Therapeutics · NCT06121011Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug
Phase 1/Phase 2 · 1 location(s) · GeneCradle Inc · NCT06391736A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects A
Phase 3 · 14 location(s) · Amicus Therapeutics · NCT04808505Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Phase N/A · 19 location(s) · Ultragenyx Pharmaceutical Inc · NCT06636383Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Technique
Phase N/A · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07336394A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Lat
Phase 1/Phase 2 · 9 location(s) · AskBio Inc · NCT07282847Pompe Pregnancy Sub-Registry
Phase N/A · 35 location(s) · Genzyme, a Sanofi Company · NCT00567073Phrenic Nerve and Diaphragm Electrophysiology in Pompe Disease
Phase N/A · 1 location(s) · IRCCS National Neurological Institute "C. Mondino" Foundatio · NCT07664930Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals
Phase 4 · 1 location(s) · Faculty Hospital Kralovske Vinohrady · NCT06875245Avalglucosidase Alfa Pregnancy Study
Phase N/A · 1 location(s) · Sanofi · NCT05734521A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD
NA · 1 location(s) · Oculox Technologies SA · NCT06557369A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Di
Phase 1/Phase 2 · 3 location(s) · Beam Therapeutics Inc. · NCT06735755Natural History of Pompe Disease
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT03564561
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.